Brandon Mahal, M.D./NEJM Study (VIDEO)

Dana-Farber Cancer Institute

Caption

Brandon Mahal, M.D. explains the difference in treatment pattern when it comes to active surveillance in African-American men with low-risk prostate cancer. He says this study demonstrates a need for more clinical research.

Credit

Dana-Farber Cancer Institute

Usage Restrictions

Please courtesy Dana-Farber Cancer Institute

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.